Ventilatory effects of impaired glial function in a brain stem chemoreceptor region in the conscious ratHOLLERAN, Julianne; BABBIE, Melissa; ERLICHMAN, Joseph S et al.Journal of applied physiology (1985). 2001, Vol 90, Num 4, pp 1539-1547, issn 8750-7587Article

A liquid chromatography-electrospray ionization tandem mass spectrometric assay for quantitation of the histone deacetylase inhibitor, vorinostat (suberoylanilide hydroxamicacid, SAHA), and its metabolites in human serumPARISE, Robert A; HOLLERAN, Julianne L; BEUMER, Jan H et al.Journal of chromatography. B. 2006, Vol 840, Num 2, pp 108-115, issn 1570-0232, 8 p.Article

In Vitro Circuit Stability of 5-Fluorouracil and Oxaliplatin in Support of Hyperthermic Isolated Hepatic PerfusionCOLVILLE, Heidi; DZADONY, Ryan; BEUMER, Jan H et al.The Journal of extra-corporeal technology. 2010, Vol 42, Num 1, pp 75-79, issn 0022-1058, 5 p.Article

Phase I Study of Vorinostat in Patients With Advanced Solid Tumors and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group StudyRAMALINGAM, Suresh S; KUMMAR, Shivaani; IVY, S. Percy et al.Journal of clinical oncology. 2010, Vol 28, Num 29, pp 4507-4512, issn 0732-183X, 6 p.Article

Embryonic stem cells lacking the epigenetic regulator Cfp1 are hypersensitive to DNA-damaging agents and exhibit decreased Ape1/Ref-1 protein expression and endonuclease activityTATE, Courtney M; FISHEL, Melissa L; HOLLERAN, Julianne L et al.DNA repair. 2009, Vol 8, Num 12, pp 1411-1423, issn 1568-7864, 13 p.Article

Pharmacokinetics, metabolism, and oral bioavailability of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine in miceBEUMER, Jan H; EISEMAN, Julie L; PARISE, Robert A et al.Clinical cancer research. 2006, Vol 12, Num 24, pp 7483-7491, issn 1078-0432, 9 p.Article

Liquid chromatography-mass spectrometric assay for quantitation of the short-chain fatty acid, 2,2-dimethylbutyrate (NSC 741804), in rat plasmaPARISE, Robert A; BEUMER, Jan H; KANGANI, Cyrous O et al.Journal of chromatography. B. 2008, Vol 862, Num 1-2, pp 168-174, issn 1570-0232, 7 p.Article

Phase I Pharmacokinetic and Pharmacodynamic Study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin, an Inhibitor of Heat-Shock Protein 90, in Patients With Advanced Solid TumorsRAMANATHAN, Ramesh K; EGORIN, Merrill J; ERLICHMAN, Charles et al.Journal of clinical oncology. 2010, Vol 28, Num 9, pp 1520-1526, issn 0732-183X, 7 p.Article

A Phase I, Pharmacokinetic and Pharmacodynamic Study on Vorinostat in Combination with 5-Fluorouracil, Leucovorin, and Oxaliplatin in Patients with Refractory Colorectal CancerFAKIH, Marwan G; PENDYALA, Lakshmi; EGORIN, Merrill J et al.Clinical cancer research (Print). 2009, Vol 15, Num 9, pp 3189-3195, issn 1078-0432, 7 p.Article

A Phase I, Pharmacokinetic, and Pharmacodynamic Study of Two Schedules of Vorinostat in Combination with 5-Fluorouracil and Leucovorin in Patients with Refractory Solid TumorsFAKIH, Marwan G; FETTERLY, Gerald; EGORIN, Merrill J et al.Clinical cancer research (Print). 2010, Vol 16, Num 14, pp 3786-3794, issn 1078-0432, 9 p.Article

Plasma pharmacokinetics, oral bioavailability, and interspecies scaling of the DNA methyltransferase inhibitor, zebularineHOLLERAN, Julianne L; PARISE, Robert A; JOSEPH, Erin et al.Clinical cancer research. 2005, Vol 11, Num 10, pp 3862-3868, issn 1078-0432, 7 p.Article

Liquid chromatography-tandem mass spectrometric assay for the quantitation in human plasma of the novel indenoisoquinoline topoisomerase I inhibitors, NSC 743400 and NSC 725776HOLLERAN, Julianne L; PARISE, Robert A; YELLOW-DUKE, Archibong E et al.Journal of pharmaceutical and biomedical analysis. 2010, Vol 52, Num 5, pp 714-720, issn 0731-7085, 7 p.Article

In vitro metabolism of the phosphatidylinositol 3-kinase inhibitor, wortmannin, by carbonyl reductaseHOLLERAN, Julianne L; FOURCADE, Julien; EGORIN, Merrill J et al.Drug metabolism and disposition. 2004, Vol 32, Num 5, pp 490-496, issn 0090-9556, 7 p.Article

Phase I Study of Vorinostat in Combination with Bortezomib for Relapsed and Refractory Multiple MyelomaBADROS, Ashraf; BURGER, Angelika M; BAER, Maria R et al.Clinical cancer research (Print). 2009, Vol 15, Num 16, pp 5250-5257, issn 1078-0432, 8 p.Article

Effect of age on the pharmacokinetics of busulfan in patients undergoing hematopoietic cell transplantation; an alliance study (CALGB 10503, 19808, and 100103)BEUMER, Jan H; OWZAR, Kouros; VIJ, Ravi et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 5, pp 927-938, issn 0344-5704, 12 p.Article

Plasma pharmacokinetics and oral bioavailability of the 3,4,5,6-tetrahydrouridine (THU) prodrug, triacetyl-THU (taTHU), in miceBEUMER, Jan H; EISEMAN, Julie L; LIHUA BAI et al.Cancer chemotherapy and pharmacology. 2011, Vol 67, Num 2, pp 421-430, issn 0344-5704, 10 p.Article

Phase I Study of Decitabine in Combination with Vorinostat in Patients with Advanced Solid Tumors and Non-Hodgkin's LymphomasSTATHIS, Anastasios; HOTTE, Sebastien J; WANG, Lisa et al.Clinical cancer research (Print). 2011, Vol 17, Num 6, pp 1582-1590, issn 1078-0432, 9 p.Article

A phase I study of vorinostat in combination with idarubicin in relapsed or refractory leukaemiaKADIA, Tapan M; HUI YANG; NEWSOME, Willie et al.British journal of haematology. 2010, Vol 150, Num 1, pp 72-82, issn 0007-1048, 11 p.Article

Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino )-17-demethoxygeldanamycin (17-DMAG), in rats and dogs : potential clinical relevanceGLAZE, Elizabeth R; LAMBERT, Amy L; EISEMAN, Julie L et al.Cancer chemotherapy and pharmacology. 2005, Vol 56, Num 6, pp 637-647, issn 0344-5704, 11 p.Article